Of the remaining AD treatments, AD6 and AD4 showing greatest similarity, while AD3 and AD5, the two AD cases that were unable to seed astrocytic tau in our long-term assay (Figure 3C), clustered more closely with controls (Ctr1-3). The gene discussed is MAPT; the disease is Alzheimer disease.